Your browser doesn't support javascript.
loading
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial.
Tobiasson, M; Dybedahl, I; Holm, M S; Karimi, M; Brandefors, L; Garelius, H; Grövdal, M; Högh-Dufva, I; Grønbæk, K; Jansson, M; Marcher, C; Nilsson, L; Kittang, A O; Porwit, A; Saft, L; Möllgård, L; Hellström-Lindberg, E.
Afiliação
  • Tobiasson M; Division of Hematology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Dybedahl I; Department of Hematology, Rikshospitalet, Oslo, Norway.
  • Holm MS; Department of Hematology, Århus University Hospital, Århus, Denmark.
  • Karimi M; Karolinska Institutet, Institution for Medicine, Stockholm, Sweden.
  • Brandefors L; Department of Medicine, Sunderbyn Hospital, Luleå, Sweden.
  • Garelius H; Department of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Grövdal M; Department of Medicine, SöDersjukhuset, Stockholm, Sweden.
  • Högh-Dufva I; Department of Hematology, Herlev University Hospital, Copenhagen, Denmark.
  • Grønbæk K; Department of Hematology, Rigshospitalet University Hospital, Copenhagen, Denmark.
  • Jansson M; Karolinska Institutet, Institution for Medicine, Stockholm, Sweden.
  • Marcher C; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Nilsson L; Department of Hematology, Lund University Hospital, Lund, Sweden.
  • Kittang AO; Department of Medicine and University of Bergen, K2 Clinical Institute 2, Haukeland University Hospital, Bergen, Norway.
  • Porwit A; Division of Hematology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Saft L; Division of Hematology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Möllgård L; Division of Hematology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
  • Hellström-Lindberg E; Division of Hematology, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Blood Cancer J ; 4: e189, 2014 Mar 07.
Article em En | MEDLINE | ID: mdl-24608733

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2014 Tipo de documento: Article